MVA-BN, also known as Imvamune, Imvanex or Jynneos

关于 MVA-BN, also known as Imvamune, Imvanex or Jynneos

There are several vaccines available for prevention of smallpox that also provide some protection against monkeypox. A newer vaccine that was developed for smallpox (MVA-BN, also known as Imvamune, Imvanex or Jynneos) was approved in 2019 for use in preventing monkeypox and is not yet widely available.

时间表

Two doses, 28 days apart, administered sub-cutaneously.

副作用

The most common (> 10%) side effects are related to the injection site, e.g., local pain, redness, swelling, induration, and itching. Occasionally, recipients may experience muscle pain, headache, fatigue, nausea and chills.

我们监测世界各地的旅行中断或威胁事件,并通知您,这样您就不会遇到任何意外情况。

了解更多